Neuralenz Secures $500k NINDS STTR Award
In September, the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS) awarded Neuralenz a $500k Phase I STTR grant for developing a new, non-invasive measurement of cerebral blood flow that could enable doctors to rapidly detect neurological damage and treat it more accurately.
read more
			
			
   
   
   
			
		
			
		
			
		
																 
																 
																 
																 
																 
																 
																 
																 
																 
																 
																 
																 
																 
																 
																 
																 
																 
																 
																 
																 
																 








